AngioDynamics (ANGO)
(Real Time Quote from BATS)
$6.38 USD
-0.08 (-1.24%)
Updated Jun 11, 2024 12:38 PM ET
4-Sell of 5 4
C Value D Growth D Momentum D VGM
Brokerage Reports
AngioDynamics, Inc. [ANGO]
Reports for Purchase
Showing records 401 - 410 ( 410 total )
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Very Strong Quarter as ANGO Rises Above Gross Margin Pressures- FY 2011 EPS Guidance a Bit Light -Timing Setback for NanoKnife U.S. Clinical Studies
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Q4 Likely In Line, Showing Continued Pressure on Core Business FY11 Consensus Numbers Appear Too High As Always, NanoKnife Progress Remains the Wild Card
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Med Tech Review and Preview: Big Players Navigate Through Maturing Markets, While BSX Woes
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Mixed Bag, Indeed: Soft Q3 Results as Pricing Pressures Erode Gross Margins Further " LC Bead Distribution Deal Extended by 1 Yr. " No Visibility on NanoKnife IDE Timing
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Likely to Hit Q3 Numbers as NanoKnife Offsets Continued Pressures on Core Business An Uncertain Path for NanoKnife IDE Studies, and Still No Visibility on LC Bead Deal
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P